Posts in category: Uncategorized

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts in routine medical settings.

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Getting just two blistering sunburns in childhood doubles the risk of getting the most dangerous skin cancer later in life. Dermatologist Bianca Tod explains what makes young children’s skins sensitive and how to make sure they are protected from the sun.

Living with a chronic illness in the family is hard. It’s even harder if you know that the person you love will get worse and won’t recover from their condition. Sadly, it can happen to any family at any time. Anyone—a grandparent, parent, sibling or partner—can develop an illness or disability.

Dry January is a somewhat recent trend in which some people stop drinking alcohol for the month of January. In general, cutting back on alcohol consumption is a good idea for our health, especially after the holidays from Thanksgiving to New Year’s, during which many of us may eat and drink more than we normally would.

A study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.

POLICE have charged two drivers with dangerous driving after they crashed into eight tombstones at Kansenshi Cemetery in Ndola yesterday. Miniva Kakunta and Duella Abaas’s ‘grave mistake’ was preceded by an earlier collision their vehicles had on Kwacha road near Kabombo junction in the friendly city of Ndola Abaas, driving a Ford Ranger, misjudged the […]

The post Drivers charged after damaging eight tombstones in Ndola first appeared on Mwebantu.

Adults screened for inactivity at well visits have lower rates of comorbid conditions, according to a study published online Jan. 2 in Preventing Chronic Disease.

Sumitomo Pharma’s Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic hyperplasia (BPH).

Socially awkward young adults are more prone to regularly binge drink, but they back off their boozing bouts as they become older and more secure.